Xuanxiao Xie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Xuanxiao Xie has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Frederique Ponchel
Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds , Leeds
2 shared publications - Gina M. Doody
Division of Haematology and Immunology, Leeds Institute of Medical Research, University of Leeds, U.K.
2 shared publications - Philip Gerard Conaghan
Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds & NIHR Leeds Biomedical Research Centre, Leeds, UK
2 shared publications - Farag Shuweihdi
Leeds Institute of Health Sciences, University of Leeds, Leeds, UK
1 shared publication - Jennifer Shrimpton
Division of Haematology and Immunology, Leeds Institute of Medical Research, University of Leeds
1 shared publication - Leendert Adrianus Trouw
Department of Immunology Leiden University Medical Center Leiden The Netherlands
1 shared publication
Latest Publications
- 1 June 2021
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 29 (6) , 924-933
Auto-antibodies to post-translationally modified proteins in osteoarthritis
- 1 June 2021
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 29 (6) , 924-933
Auto-antibodies to post-translationally modified proteins in osteoarthritis
- Open Access
- 12 March 2021
- Published by Wiley in Aging Cell
- Vol. 20 (4) , e13341
B‐cell capacity for differentiation changes with age
Background: Age‐related immune deficiencies are thought to be responsible for increased susceptibility to infection in older adults, with alterations in lymphocyte populations becoming more prevalent over time. The loss of humoral immunity in ageing was attributed to the diminished numbers of B cells and the reduced ability to generate immunoglobulin.Aims: To compare the intrinsic B‐cell capacity for differentiation into mature plasma cells (PCs), between young and old donors, using in vitro assays, providing either effective T‐cell help or activation via TLR engagement.Methods: B cells were isolated from healthy individuals, in younger (30–38 years) and older (60–64 years) donors. An in vitro model system of B‐cell differentiation was used, analysing 5 differentiation markers by flow cytometry, under T‐dependent (TD: CD40/BCR stimulation) or T‐independent (TI: TLR7/BCR activation) conditions. Antibody secretion was measured by ELISA and gene expression using qPCR.Results: TI and TD differentiation resulted in effective proliferation of B cells followed by their differentiation into PC. B‐cell‐executed TI differentiation was faster, all differentiation marker and genes being expressed earlier than under TD differentiation (day 6), although generating less viable cells and lower antibody levels (day 13). Age‐related differences in B‐cell capacity for differentiation were minimal in TD differentiation. In contrast, in TI differentiation age significantly affected proliferation, viability, differentiation, antibody secretion and gene expression, older donors being more efficient.Conclusion: Altogether, B‐cell differentiation into PC appeared similar between age groups when provided with T‐cell help, in contrast to TI differentiation, where multiple age‐related changes suggest better capacities in older donors. These new findings may help explain the emergence of autoantibodies in ageing.
- 12 March 2021
- Published by Wiley in Aging Cell
- Vol. 20 (4) , e13341
Open AccessB‐cell capacity for differentiation changes with age
Background: Age‐related immune deficiencies are thought to be responsible for increased susceptibility to infection in older adults, with alterations in lymphocyte populations becoming more prevalent over time. The loss of humoral immunity in ageing was attributed to the diminished numbers of B cells and the reduced ability to generate immunoglobulin.Aims: To compare the intrinsic B‐cell capacity for differentiation into mature plasma cells (PCs), between young and old donors, using in vitro assays, providing either effective T‐cell help or activation via TLR engagement.Methods: B cells were isolated from healthy individuals, in younger (30–38 years) and older (60–64 years) donors. An in vitro model system of B‐cell differentiation was used, analysing 5 differentiation markers by flow cytometry, under T‐dependent (TD: CD40/BCR stimulation) or T‐independent (TI: TLR7/BCR activation) conditions. Antibody secretion was measured by ELISA and gene expression using qPCR.Results: TI and TD differentiation resulted in effective proliferation of B cells followed by their differentiation into PC. B‐cell‐executed TI differentiation was faster, all differentiation marker and genes being expressed earlier than under TD differentiation (day 6), although generating less viable cells and lower antibody levels (day 13). Age‐related differences in B‐cell capacity for differentiation were minimal in TD differentiation. In contrast, in TI differentiation age significantly affected proliferation, viability, differentiation, antibody secretion and gene expression, older donors being more efficient.Conclusion: Altogether, B‐cell differentiation into PC appeared similar between age groups when provided with T‐cell help, in contrast to TI differentiation, where multiple age‐related changes suggest better capacities in older donors. These new findings may help explain the emergence of autoantibodies in ageing.